Volume 74, Issue 12, Pages (December 2008)

Slides:



Advertisements
Similar presentations
Figure 1 Schematic representation of idiopathic nephrotic syndrome,
Advertisements

Volume 81, Issue 2, Pages (January 2012)
Volume 82, Issue 9, Pages (November 2012)
The Renal Pathology of Obesity
Volume 88, Issue 5, Pages (November 2015)
Volume 66, Issue 5, Pages (November 2004)
Volume 78, Issue 8, Pages (October 2010)
Volume 65, Issue 5, Pages (May 2004)
Renal manifestations in Fabry disease and therapeutic options
Volume 85, Issue 4, Pages (April 2014)
Volume 80, Issue 12, Pages (December 2011)
Volume 76, Issue 12, Pages (December 2009)
Volume 86, Issue 6, Pages (December 2014)
Volume 74, Issue 12, Pages (December 2008)
Volume 80, Issue 10, Pages (November 2011)
Glomerular disease related to anti-VEGF therapy
Pdlim2 is a novel actin-regulating protein of podocyte foot processes
Volume 84, Issue 2, Pages (August 2013)
Kumar Sharma, Ljiljana Paša-Tolić  Kidney International 
Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga 
Volume 64, Issue 1, Pages (July 2003)
Volume 57, Issue 3, Pages (March 2000)
Rutger J.H. Maas, Jack F.M. Wetzels, Jeroen K.J. Deegens
Glomerular filtration: the charge debate charges ahead
Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial  Jeroen K.J. Deegens, Jack F.M. Wetzels 
Peripheral microvascular parameters in the nephrotic syndrome
Volume 62, Issue 1, Pages (July 2002)
The spectrum of kidney biopsy findings in patients with morbid obesity
Volume 70, Issue 8, Pages (October 2006)
Volume 71, Issue 1, Pages (January 2007)
Serum-soluble urokinase receptor concentration in primary FSGS
Volume 78, Issue 5, Pages (September 2010)
Volume 73, Issue 7, Pages (April 2008)
Volume 59, Issue 4, Pages (April 2001)
Volume 82, Issue 9, Pages (November 2012)
Volume 79, Issue 6, Pages (March 2011)
Tarak Srivastava, Robert E. Garola, Joan M. Whiting, Uri S. Alon 
Volume 66, Issue 5, Pages (November 2004)
Volume 68, Issue 4, Pages (October 2005)
Volume 85, Issue 3, Pages (March 2014)
Infected glomerulus Kidney International
Synaptopodin expression in idiopathic nephrotic syndrome of childhood
Therapy of relapsing minimal-change disease in adults: a new approach?
Obesity-related glomerulopathy: An emerging epidemic
Volume 82, Issue 1, Pages 3-4 (July 2012)
Volume 69, Issue 5, Pages (March 2006)
Volume 72, Issue 12, Pages (December 2007)
Volume 85, Issue 3, Pages (March 2014)
J.M. van den Akker, J.F.M. Wetzels, A.J. Hoitsma  Kidney International 
Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske 
Volume 85, Issue 5, Pages (May 2014)
Red cell traverse through thin glomerular basement membranes
Nephrology Crossword: Glomerulonephritis
Emerging role of B cells in chronic allograft dysfunction
Volume 71, Issue 4, Pages (February 2007)
Antiglomerular basement membrane disease with normal renal function
Volume 70, Issue 2, Pages (July 2006)
The Case ∣ The eyes have it!
The Case ∣ An Asian boy with proteinuria
The changing face of childhood nephrotic syndrome
Membranous nephropathy: recent travels and new roads ahead
Dana V. Rizk, David G. Warnock  Kidney International 
The international realities of live donor kidney transplantation
Volume 55, Issue 4, Pages (April 1999)
Prediction in idiopathic membranous nephropathy
Bisphosphonate nephrotoxicity
Volume 56, Issue 6, Pages (December 1999)
The Ebf1 knockout mouse and glomerular maturation
C1q nephropathy: A variant of focal segmental glomerulosclerosis
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Presentation transcript:

Volume 74, Issue 12, Pages 1568-1576 (December 2008) Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis  Jeroen K.J. Deegens, Henry B.P.M. Dijkman, George F. Borm, Eric J. Steenbergen, José G. van den Berg, Jan J. Weening, Jack F.M. Wetzels  Kidney International  Volume 74, Issue 12, Pages 1568-1576 (December 2008) DOI: 10.1038/ki.2008.413 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Median foot process width with 95% confidence interval in patients with FSGS, minimal change nephrotic syndrome and controls. Kidney International 2008 74, 1568-1576DOI: (10.1038/ki.2008.413) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Proteinuria versus foot process width in the individual patients with idiopathic FSGS (▴), minimal change nephrotic syndrome (•), FSGS secondary to maladaptive responses (▵) and possible secondary FSGS (▿*). *These patients were not included in the statistical analysis. Kidney International 2008 74, 1568-1576DOI: (10.1038/ki.2008.413) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Foot process width of patients with idiopathic FSGS (▴), minimal change nephrotic syndrome (MCNS; •), FSGS secondary to maladaptive responses (▵), or possible secondary FSGS (▿*). Median foot process width is indicated by horizontal line. *These patients were not included in the statistical analysis. Kidney International 2008 74, 1568-1576DOI: (10.1038/ki.2008.413) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Foot process width of patients with FSGS NOS, FSGS tip variant, perihilar FSGS, or minimal change nephrotic syndrome (MCNS). Median foot process width is indicated by horizontal line. ▴=idiopathic FSGS, ▵=FSGS secondary to maladaptive responses, ▿*=possible secondary FSGS, •=MCNS. *These patients were not included in the statistical analysis. Kidney International 2008 74, 1568-1576DOI: (10.1038/ki.2008.413) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 5 Electron microscopic photographs to illustrate the difference between separate foot processes and foot process fusion. (a) Example of two separate foot processes. The lateral membranes of the foot processes, indicated by white dotted lines, are identifiable over the entire length from the apical side to the glomerular basement membrane (GBM). CL; capillary lumen. (b) Example of fused foot processes. The lateral membranes (white dotted lines) merge near the glomerular basement membrane (GBM) and are not identifiable over the entire length. CL; capillary lumen. Kidney International 2008 74, 1568-1576DOI: (10.1038/ki.2008.413) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 6 Representative electron microscopic image of a glomerulus from a patient with idiopathic FSGS. The separations between the foot processes have been marked with arrows in the detailed images a–e. CL; capillary lumen; GBM; glomerular basement membrane. Kidney International 2008 74, 1568-1576DOI: (10.1038/ki.2008.413) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 7 Representative electron microscopic image of a glomerulus from a patient with FSGS secondary to maladaptive responses. The separations between the foot processes have been marked with arrows in the detailed images (a–d). CL; capillary lumen, GBM; glomerular basement membrane. Kidney International 2008 74, 1568-1576DOI: (10.1038/ki.2008.413) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 8 Representative electron microscopic image of a glomerulus from a patient with minimal change nephrotic syndrome. The separations between the foot processes have been marked with arrows in the detailed images (a–f). CL; capillary lumen, GBM; glomerular basement membrane. Kidney International 2008 74, 1568-1576DOI: (10.1038/ki.2008.413) Copyright © 2008 International Society of Nephrology Terms and Conditions